Antitumor Activity of α-Linolenic Acid-Paclitaxel Conjugate Nanoparticles: In vitro and in vivo

PURPOSE: Small molecule modified antitumor drug conjugate nanoparticles have the advantages of high drug loading, simple synthesis and preparation, and better biocompatibility. Due to the large demand for exogenous α-linolenic acid (ALA) by tumor cells, we synthesized α-linolenic acid-paclitaxel con...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Mei-Qi, Hao, Yan-Li, Wang, Jing-Ru, Li, Zhuo-Yue, Li, Hui, Feng, Zhen-Han, Wang, Hui, Wang, Jing-Wen, Zhang, Xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558831/
https://www.ncbi.nlm.nih.gov/pubmed/34737564
http://dx.doi.org/10.2147/IJN.S331578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558831/
https://www.ncbi.nlm.nih.gov/pubmed/34737564
http://dx.doi.org/10.2147/IJN.S331578

Ejemplares similares